Pulmonary Fibrosis News Home | Pulmonary Fibrosis News
WEBMy name is Sam. I was diagnosed with idiopathic pulmonary fibrosis (IPF) in January 2017, and I hate this disease. My life was extended by a bilateral lung transplant in July 2021, thanks to an unknown donor who gave me a gift for which the value cannot…. Read more. August 30, 2024 News by Lindsey Shapiro, PhD.
BMS-986278 declared breakthrough therapy for progressive PF
WEBOct 27, 2023 · The FDA’s decision to grant breakthrough therapy designation to BMS-986278 was based on results from a global Phase 2 clinical trial (NCT04308681) assessing the safety and efficacy of BMS-986278 in 278 people with idiopathic PF (IPF) and progressive PF. Patients were assigned randomly to receive either 30 or 60 mg of the therapy, or a placebo ...
Pulmonary Fibrosis Symptoms, Diagnosis, Prognosis and Treatment
WEBRecent Posts. Immune cells separate IPF, fibrotic hypersensitivity pneumonitis September 6, 2024; Tales of 2 women, both named Melissa, on their IPF journeys September 3, 2024; Patient journeys highlighted for this year’s PF Awareness Month August 30, 2024 ‘You can’t have that’: The diet restrictions since my transplant August 27, 2024; Phase 1b trial launched of inhaled nintedanib for ...
Approved Treatments for Pulmonary Fibrosis
WEBHere are approved treatments for pulmonary fibrosis that can improve symptoms or slow the disease’s progression: Ofev (nintedanib) is an approved anti-fibrotic drug the American doctors use to treat PF. In clinical trials, it slowed the decline in lung function in mild-to-moderate IPF. It works by inhibiting excess production of growth ...
Pulmonary Fibrosis Study Shows Enzyme Can Help Reverse Scarring
WEBby José Lopes, PhD February 19, 2018. An enzyme can start a chain of events that leads to cells involved in tissue scarring reversing their fibrosis-generating activity, British and American researchers have discovered. The study dealt with the enzyme’s effect on myofibroblasts — cells involved in wound healing and inflammatory response.
What Is Pulmonary Fibrosis?
WEBSep 24, 2021 · Pulmonary fibrosis (PF), as its name suggests, is a disease marked by scarring — or fibrosis — of the lungs, leading to shortness of breath. PF is part of a larger group of more than 200 lung conditions collectively known as interstitial lung diseases (ILDs), many of which are known to cause progressive fibrosis.. Types and causes of PF. In most cases, the exact cause of lung scarring is ...
12 Facts About Pulmonary Fibrosis Prognosis and Life Expectancy
WEBAug 16, 2019 · The average life expectancy of patients with pulmonary fibrosis is three to five years after diagnosis. However, early detection of the disease is key to slowing progression, and conditions such as chronic obstructive pulmonary disease (COPD) or pulmonary arterial hypertension (PAH) can impact disease prognosis.
Diagnosis of Pulmonary Fibrosis
WEBA high-resolution computerized tomography (HRCT) scan can produce more detailed images of the lungs, allowing physicians to better determine the extent of lung damage, as well as identify specific patterns of fibrosis, such as honeycombing, which is a common feature of idiopathic pulmonary fibrosis.. An echocardiogram, a test that uses sound waves to produce images of the heart, also may be ...
Pulmonary Fibrosis Lung Transplant
WEBAccording to the Scientific Registry of Transplant Recipients, 98.4% of patients survive the first year, 74.8% of patients survive three years, and 61.2% survive five years. The study “ Lung transplantation for idiopathic pulmonary fibrosis,” by researchers from the Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic ...
NP-120, Potential IPF Treatment, Stabilizes Lung Function in Trial
WEBJul 19, 2022 · Most idiopathic pulmonary fibrosis (IPF) patients treated with NP-120 (ifenprodil) in a 12-week clinical trial saw their lung function improve or stabilize, and most also experienced an easing in coughing, according to top-line data announced by the therapy’s developer, Algernon Pharmaceuticals.